Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$8.63 - $12.56 $55,309 - $80,497
-6,409 Reduced 61.76%
3,969 $36,000
Q1 2024

May 06, 2024

BUY
$9.86 - $13.74 $102,327 - $142,593
10,378 New
10,378 $128,000
Q3 2023

Nov 07, 2023

BUY
$6.95 - $9.89 $46,426 - $66,065
6,680 Added 41.61%
22,732 $181,000
Q2 2023

Aug 08, 2023

BUY
$8.59 - $14.56 $30,820 - $52,241
3,588 Added 28.79%
16,052 $153,000
Q1 2023

May 12, 2023

BUY
$9.53 - $16.8 $55,369 - $97,608
5,810 Added 87.32%
12,464 $149,000
Q4 2022

Feb 13, 2023

BUY
$8.71 - $14.28 $57,956 - $95,019
6,654 New
6,654 $92,000
Q2 2022

Aug 09, 2022

SELL
$5.78 - $8.87 $62,655 - $96,150
-10,840 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$5.14 - $9.35 $55,717 - $101,354
10,840 New
10,840 $67,000
Q4 2020

Feb 12, 2021

SELL
$11.65 - $17.94 $35,509 - $54,681
-3,048 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$12.98 - $25.98 $27,881 - $55,805
2,148 Added 238.67%
3,048 $53,000
Q2 2020

Aug 13, 2020

BUY
$9.06 - $23.49 $8,154 - $21,141
900 New
900 $22,000

Others Institutions Holding ZYXI

About ZYNEX INC


  • Ticker ZYXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 37,453,400
  • Market Cap $308M
  • Description
  • Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...
More about ZYXI
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.